RTTNews | Mar 15, 2021 07:01AM EDT

07:00 Monday, March 15, 2021 (RTTNews.com) - Beam Therapeutics Q4 Net Loss Attributable To Common Stockholders $95.5 Mln Or $1.69 Per Share

For comments and feedback: contact editorial@rttnews.com

https://www.rttnews.comCopyright(c) 2021 RTTNews.com All Rights Reserved